BIOMAT Database Logo BIOMAT Database Logo

[Clinical study of a new hypoglycemic sulfamide: glibenclamide or HB 419]. 1969

M Plauchu

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Plauchu
[Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
February 1969, Diabetologia,
M Plauchu
[Comparative clinical study of the oral hypoglycemic agent HB 419 or glibenclamide].
November 1972, Revista clinica espanola,
M Plauchu
[A new particularly active hypoglycemic sulfonamide, HB 419 (glibenclamide)].
September 1968, Le Diabete,
M Plauchu
Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
June 1972, Israel journal of medical sciences,
M Plauchu
A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
April 1972, Singapore medical journal,
M Plauchu
[Clinical trial of a new antidiabetic active by oral route: glibenclamide or HB 419 Hoechst].
February 1970, Revue medicale de Liege,
M Plauchu
[Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
August 1969, Arzneimittel-Forschung,
M Plauchu
A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent.
May 1970, Applied therapeutics,
M Plauchu
Glibenclamide (HB 419): a new oral antidiabetic of sulphonylurea type.
August 1969, German medical monthly,
M Plauchu
Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes.
August 1971, Australian and New Zealand journal of medicine,
Copied contents to your clipboard!